These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3133685)

  • 21. Neuroendocrine abnormalities in panic disorder.
    Roy-Byrne PP; Uhde TW; Gold PW; Rubinow DR; Post RM
    Psychopharmacol Bull; 1985; 21(3):546-50. PubMed ID: 3875875
    [No Abstract]   [Full Text] [Related]  

  • 22. Pilot investigation of thyrotropin-releasing hormone-induced thyrotropin and prolactin release in anxious patients treated with diazepam.
    Humbert T; Pujalte D; Bottaï T; Hüe B; Pouget R; Petit P
    Clin Neuropharmacol; 1998; 21(2):80-5. PubMed ID: 9579292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response.
    Winokur A; Caroff SN; Amsterdam JD; Maislin G
    Biol Psychiatry; 1984 May; 19(5):695-702. PubMed ID: 6428472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder.
    Rapaport MH; Risch SC; Gillin JC; Golshan S; Janowsky DS
    Am J Psychiatry; 1989 Jan; 146(1):92-5. PubMed ID: 2492166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using the protirelin test to distinguish mania from schizophrenia.
    Extein I; Pottash AL; Gold MS; Cowdry RW
    Arch Gen Psychiatry; 1982 Jan; 39(1):77-81. PubMed ID: 6798950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protirelin stimulation test and thyroid function during treatment of depression.
    Kirkegaard C; Norlem N; Lauridsen UB; Bjorum N; Christiansen C
    Arch Gen Psychiatry; 1975 Sep; 32(9):1115-8. PubMed ID: 810113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some biological aspects of panic disorder.
    Evans L
    Int J Clin Pharmacol Res; 1989; 9(2):139-45. PubMed ID: 2654036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid hormone levels in panic disorder.
    Yeragani VK; Rainey JM; Pohl R; Ortiz A; Weinberg P; Gershon S
    Can J Psychiatry; 1987 Aug; 32(6):467-9. PubMed ID: 3690476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct effect of protirelin (TRH) on PB[123I] in autonomous thyroid adenoma.
    Kallee E; Müh U; Wahl R
    Thyroidology; 1993 Dec; 5(3):81-5. PubMed ID: 7524634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inverse relationship between CSF TRH concentrations and the TSH response to TRH in abstinent alcohol-dependent patients.
    Adinoff B; Nemeroff CB; Bissette G; Martin PR; Linnoila M
    Am J Psychiatry; 1991 Nov; 148(11):1586-8. PubMed ID: 1656797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buccal absorption of protirelin: an effective way to stimulate thyrotropin and prolactin.
    Anders R; Merkle HP; Schurr W; Ziegler R
    J Pharm Sci; 1983 Dec; 72(12):1481-3. PubMed ID: 6420539
    [No Abstract]   [Full Text] [Related]  

  • 33. Variability of TRH test responses in depressed and normal elderly subjects.
    Targum SD; Marshall LE; Fischman P
    Biol Psychiatry; 1992 Apr; 31(8):787-93. PubMed ID: 1643193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
    Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G
    Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in TRH-stimulated TSH and prolactin in primary degenerative dementia and elderly controls.
    Dysken MW; Falk A; Pew B; Kuskowski M; Krahn DD
    Biol Psychiatry; 1990 Jul; 28(2):144-50. PubMed ID: 2116189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [TRH test II. Stimulation with thyrotropin releasing hormone(TRH) in patients with thyroid diseases].
    Dige-Petersen H; Hummer L
    Ugeskr Laeger; 1974 Jun; 136(25):1356-60. PubMed ID: 4210164
    [No Abstract]   [Full Text] [Related]  

  • 37. [The TRH test in normal subjects and in thyroid pathology: behavior of plasma TSH after stimulation with hypothalamic TRH (thyrotropin releasing hormone)].
    Portioli I; Modena G; Rocchi F; Fantesini C; Buia M; Dotti C
    Ateneo Parmense Acta Biomed; 1973 Sep; 44(5):307-21. PubMed ID: 4210983
    [No Abstract]   [Full Text] [Related]  

  • 38. Panic disorder and somatization. Review of 55 cases.
    Katon W
    Am J Med; 1984 Jul; 77(1):101-6. PubMed ID: 6377887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP; Owings J; Hayford JT; Blizzard RM
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone response to clonidine in panic disorder patients.
    Schittecatte M; Charles G; Depauw Y; Mesters P; Wilmotte J
    Psychiatry Res; 1988 Feb; 23(2):147-51. PubMed ID: 3363023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.